Clinical trial for Schizophrenia / Schizoaffective Disorder
Official title tACS for Self-Other Boundary in Schizophrenia
ClinicalTrials.gov ID: NCT07818668
What this study is testing
- What it's testing
- The study wants to learn how people with schizophrenia process self‑vs‑other information and to see if tACS can improve that ability.
- Who it's for
- It looks for adults who have schizophrenia or related symptoms.
- What's involved
- Participants will do computer face‑recognition tasks while wearing an EEG cap, receive daily 20‑minute tACS or a sham treatment for five days, and complete questionnaires.
- Time commitment
- The study lasts about one week, with daily visits for stimulation and testing, plus a follow‑up visit 48 hours after the last session.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Diagnosis of schizophrenia according to DSM-5 criteria
- Presence of hallucinations or delusions
- Age between 18 and 50 years
- Clinically stable on a stable dose of antipsychotic medication for at least 4 weeks prior to enrollment, with no anticipated medication changes...
- Normal or corrected-to-normal vision (≥ 20/40) as assessed by standard visual acuity test
You likely can't join if
- History of neurological disorders (e.g., epilepsy, stroke, traumatic brain injury)
- Presence of other major psychiatric disorders (e.g., bipolar disorder, major depressive disorder)
- Previous receipt of non-invasive brain stimulation (e.g., tACS, tDCS, rTMS)
- History of substance dependence or abuse within the past 6 months
- Metal implants in the head or skull (e.g., cochlear implants, deep brain stimulators)
- Pregnancy or breastfeeding
See the full eligibility criteria
- Diagnosis of schizophrenia according to DSM-5 criteria
- Presence of hallucinations or delusions
- Age between 18 and 50 years
- Clinically stable on a stable dose of antipsychotic medication for at least 4 weeks prior to enrollment, with no anticipated medication changes during the study period
- Normal or corrected-to-normal vision (≥ 20/40) as assessed by standard visual acuity test
- Able to understand and provide written informed consent
- History of neurological disorders (e.g., epilepsy, stroke, traumatic brain injury)
- Presence of other major psychiatric disorders (e.g., bipolar disorder, major depressive disorder)
- Previous receipt of non-invasive brain stimulation (e.g., tACS, tDCS, rTMS)
- History of substance dependence or abuse within the past 6 months
- Metal implants in the head or skull (e.g., cochlear implants, deep brain stimulators)
- Pregnancy or breastfeeding
- Presence of skin lesions, wounds, or sensitive skin at electrode placement sites (Fpz, AF7, AF8, F5, F6)
The study team makes the final eligibility decision.
Where it is enrolling
- Hefei, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hefei, Anhui, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.